Overview

Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the usefulness of a medication (Levetiracetam) for people with body dysmorphic disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Butler Hospital
Collaborator:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam